Westview Investment Advisors’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.79M Sell
30,563
-38
-0.1% -$1.59K 0.88% 43
2026
Q1
$986K Sell
30,601
-2,089
-6% -$77.3K 0.51% 51
2025
Q4
$1.38M Buy
+32,690
New +$1.32M 0.66% 46

Other funds holding VCYT

Westview Investment Advisors's VCYT Position: Q2 2026 in Review

Westview Investment Advisors reduced its Veracyte (VCYT) stake by 0.12% in Q2 2026, selling an estimated $1.59K and leaving 30,563 shares worth $1.79M. The position accounts for 0.88% of the portfolio, ranked #43.

Westview Investment Advisors first reported a position in VCYT in Q4 2025 and has held it in 3 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Westview Investment Advisors held 30,563 shares of Veracyte worth $1.79M as of Q2 2026.
  • Westview Investment Advisors sold 38 Veracyte shares in Q2 2026, an estimated $1.59K.
  • Veracyte made up 0.88% of Westview Investment Advisors's portfolio in Q2 2026, its #43 holding.
  • Westview Investment Advisors first reported a position in Veracyte in Q4 2025 and has held it in 3 quarters since.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Westview Investment Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.